Ticker brief
ANGO ANGIODYNAMICS INC
Consumer, Non-cyclical · Healthcare-Products
last close
$11.05
1 day
+1.4%
14 days
-28.2%
mkt cap
·
signals 14d
21
authors 14d
14
crowd 14d
-1.3σ
Sentiment — last 14 days
daily mean sentiment, 2026-10-02 → 2026-10-13 · now +0.15 (−1 bearish … +1 bullish)
Who spoke14
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @PrismMarketView | C | · | 5 | -0.01 |
| @OpenOutcrier | C | · | 2 | +0.30 |
| @wallstengine | B | -1.14 | 2 | +0.32 |
| @Tickeron | C | +1.53 | 2 | +0.15 |
| @Trading_Sunset | C | -2.68 | 1 | +0.60 |
| @JaguarAnalytics | B | -0.08 | 1 | +0.30 |
| @Cd_Investidores | C | -1.65 | 1 | +0.00 |
| @GetPursa | C | +0.10 | 1 | +0.00 |
| @EmmanuelInvest | C | -1.12 | 1 | +0.60 |
| @FwdQuarter | C | · | 1 | +0.35 |
| @UTEX_io | C | +0.04 | 1 | -0.60 |
| @TWFeditor | C | -1.36 | 1 | -0.70 |
| @PrismDM | A | -2.76 | 1 | +0.30 |
| @DonJamesTrades | C | · | 1 | +0.00 |
Recent signals21of 21 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-13 | @PrismMarketView | +0.15 | Presents three public companies as a thrombosis-treatment technology basket. | +1.4% | tweet ↗ |
| 2026-10-10 | @PrismMarketView | +0.40 | Reports strong preliminary revenue growth, FDA clearance and sustained MedTech growth. | -4.1% | tweet ↗ |
| 2026-10-10 | @Tickeron | +0.15 | Reports ANGO volume reached 255% of its 65-day moving average. | -4.1% | tweet ↗ |
| 2026-10-09 | @DonJamesTrades | +0.00 | Lists the day's macro release schedule and six notable U.S. earnings names. | -4.1% | tweet ↗ |
| 2026-10-08 | @PrismMarketView | -0.55 | Quantifies sector-index and single-stock winners and losers during a risk-off session. | -1.6% | tweet ↗ |
| 2026-10-08 | @Tickeron | +0.15 | Reports a headline earnings beat alongside weak quality concerns and a CEO transition. | -1.6% | tweet ↗ |
| 2026-10-08 | @PrismDM | +0.30 | Reports an estimate beat, reiterated guidance and an upcoming CEO change. | -1.6% | tweet ↗ |
| 2026-10-08 | @PrismMarketView | -0.20 | Reports a coming CEO change amid a 21% drop despite an estimate beat and reiterated guidance. | -1.6% | tweet ↗ |
| 2026-10-08 | @TWFeditor | -0.70 | Reports a steep ANGO decline eroding fundholder gains. | -1.6% | tweet ↗ |
| 2026-10-08 | @UTEX_io | -0.60 | AngioDynamics reported a narrower-than-expected loss but missed Wall Street revenue estimates. | -1.6% | tweet ↗ |
| 2026-10-08 | @OpenOutcrier | +0.60 | AngioDynamics beat Q1 2026 forecasts despite a premarket share decline. | -1.6% | tweet ↗ |
| 2026-10-08 | @FwdQuarter | +0.35 | Reports Q1 sales, EBITDA, segment growth and FY27 revenue guidance without estimates. | -1.6% | tweet ↗ |
| 2026-10-08 | @EmmanuelInvest | +0.60 | AngioDynamics beat revenue and EPS estimates while reiterating FY27 guidance; a CEO transition was also announced. | -1.6% | tweet ↗ |
| 2026-10-08 | @wallstengine | +0.65 | AngioDynamics beat Q1 revenue and EPS estimates, affirmed guidance and announced FDA IDE approval. | -1.6% | tweet ↗ |
| 2026-10-08 | @GetPursa | +0.00 | Six stocks were placed on a watch list, but the tweet supplies no directional evidence. | -1.6% | tweet ↗ |
| 2026-10-07 | @Cd_Investidores | +0.00 | Lists today's macro events and premarket corporate reports | -22.1% | tweet ↗ |
| 2026-10-07 | @wallstengine | +0.00 | Lists the day's macro schedule and before-open earnings reporters. | -22.1% | tweet ↗ |
| 2026-10-07 | @OpenOutcrier | +0.00 | Lists upcoming after-hours and premarket earnings reporters. | -22.1% | tweet ↗ |
| 2026-10-04 | @JaguarAnalytics | +0.30 | Presents four earnings setups built around allegedly underappreciated assumptions or catalysts. | -26.9% | tweet ↗ |
| 2026-10-04 | @Trading_Sunset | +0.60 | Long-term bullish on ANGO from its March 2024 low ahead of Thursday earnings. | -26.9% | tweet ↗ |
| 2026-10-02 | @PrismMarketView | +0.15 | Summarizes product-performance, commercialization, collaboration and research-funding updates across four medtech firms. | -26.9% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.